Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -0.40%222.301.9%$342.42m
TEVATeva Pharmaceutical Industries Ltd. -1.65%8.032.0%$79.79m
RDYDr. Reddy's Laboratories Ltd. -2.76%60.682.0%$7.46m
TXMDTherapeuticsMD, Inc. -5.02%0.4714.2%$2.58m
JAGXJaguar Health, Inc. -7.09%1.182.6%$1.71m
TAROTaro Pharmaceutical Industries Ltd. -1.81%51.006.6%$0.74m
COCPCocrystal Pharma, Inc. -7.60%0.710.0%$0.62m
ABEOAbeona Therapeutics, Inc. -4.31%0.583.7%$0.55m
LFVNLifeVantage Corp. -3.40%6.253.6%$0.35m
CPHIChina Pharma Holdings, Inc. -5.10%0.500.1%$0.22m

Company Profile

Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.